Inceptionr LLC Incyte Corp Transaction History

Inceptionr LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$56.55 - $66.59 $708,741 - $834,572	12,533 Added 329.12%	16,341 $931 Million
Q4 2023 Feb 08, 2024	SELL	$52.16 - $64.19 $342,952 - $422,049	-6,575 Reduced 63.32%	3,808 $239 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $599,825 - $684,551	10,383 New	10,383 $600 Million
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $1.05 Million - $1.29 Million	15,019 New	15,019 $1.09 Billion

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

Stay updated on Inceptionr LLC with notifications on news.